Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?
Philip J; Dutta Roy S; Ballal M; Foster CS; Javl P Department of Urology, Leighton Hospital, Crewe, UK. indianajoe72@yahoo.com OBJECTIVE: To assess the role of a digital rectal examination (DRE) in the clinical diagnosis of prostate cancer and in predicting the pathological stage, as the diagnosis of early prostate cancer usually comprises prostate-specific antigen (PSA) testing, a DRE and transrectal ultrasonography (TRUS)-guided biopsies. PATIENTS AND METHODS: Over the 4 years between 2000 and 2004, 408 consecutive patients (mean age 63.8 years) referred with age-specific PSA levels of 2.5-10.0 ng/mL and who had a TRUS-guided 12-core prostate biopsy were included in the study. They had a DRE by either of two experienced consultant urologists. The results of the DRE and core biopsy histology were compared with the histology and the radical prostatectomy specimen in a subset (82 men) of the study population. RESULTS: Cancer was detected on biopsy in 152 patients; of the 196 with an abn
Related Questions
- Is there any clinical parameter able to predict prostate cancer after initial diagnosis of atypical small acinar proliferation?
- Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?
- How Adequate is Digital Rectal Exam for Prostate Cancer Screening at Colonoscopy?
